U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 16-22, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 16-22, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 06/17/2024
Location: Washington, DC
Subject: American Public Health Association - Policy Action Institute
FDA Participant/Group: SHANNON HATCH; STACY MATHEW;
Non FDA Participant/Group: Academia, industry, media, and other registered attendees

Event Date: 06/18/2024
Location: San Diego, CA
Subject: Drug Information Association (DIA) Global Annual Meeting – International Regulatory Convergence: Regulatory Science to Address Challenges Brought by Pharmaceutical Innovation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, media, and other registered attendees

Event Date: 06/18/2024
Location: San Diego, CA
Subject: Food Safety Updates and Collaboration Efforts on Oncology and Gene Therapy
FDA Participant/Group: JASON STRACHMAN MILLER;
Non FDA Participant/Group: Pamela Aung-Thin, Stephanie Millius (Health Canada Health Products and Food Branch);

Event Date: 06/19/2024
Location: San Diego, CA
Subject: Drug Information Association (DIA) Global Annual Meeting – International Coalition of Medicines Regulatory Authorities (ICMRA) Post-Pandemic: Regulators Looking into the Future
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, media, and other registered attendees

Event Date: 06/21/2024
Location: San Diego, CA
Subject: American Diabetes Association 84th Scientific Sessions; The Dissociation Between Technology Advances and Health Outcomes for Diabetes in the US: What Should We Do Differently?
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, media, and other registered attendees

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 06/17/2024
Location: Virtual
Subject: Nutrition Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Consumer and public health organizations

Event Date: 06/17/2024
Location: Virtual
Subject: Nutrition and Human Foods Program Update
FDA Participant/Group: LAURA CARROLL; JANESIA ROBBS; ROBIN MCKINNON;
Non FDA Participant/Group: Dan Christenson, René Lammers (PepsiCo);

Event Date: 06/21/2024
Location: Virtual
Subject: Laboratory Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Staff and members of the American Council of Independent Laboratories

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 06/18/2024
Location: Silver Spring, MD
Subject: Medical Products and Safety Collaboration
FDA Participant/Group: MARK ABDOO; ALONZA CRUSE; JENNIFER MAGUIRE; JOHN WEINER; CELIA GABREL; JILL FURMAN; MARC THEORET; C MICHELLE LIMOLI; QIAN WANG;
Non FDA Participant/Group: Jia Xuan, LV Ling, Liang Hong, Yuan Peng, Zhang Ying, Zheng Jia (National Medical Products Administration);

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 06/20/2024
Location: Nairobi, Kenya
Subject: Introductory Meeting
FDA Participant/Group: JOHN WEINER; BETSY NEWCOMER; ANNA FERUS;
Non FDA Participant/Group: Mary Muthoni Muriuki (Kenya Ministry of Health);

Event Date: 06/20/2024
Location: Nairobi, Kenya
Subject: FDA Global Work and New Focused Work in Africa
FDA Participant/Group: BETSY NEWCOMER; ANNA FERUS; JOHN WEINER;
Non FDA Participant/Group: Abdourahmane Diallo (World Health Organization);

Event Date: 06/20/2024
Location: Nairobi, Kenya
Subject: Continued Engagement
FDA Participant/Group: BETSY NEWCOMER; ANNA FERUS; JOHN WEINER;
Non FDA Participant/Group: Members of the Kenya Pharmacy and Poisons Board

Event Date: 06/21/2024
Location: Nairobi, Kenya
Subject: Kenyan Development and Manufacture of Medical Products
FDA Participant/Group: BETSY NEWCOMER; ANNA FERUS; JOHN WEINER;
Non FDA Participant/Group: Michael Lusiola (Kenya Ministry of Health);

Event Date: 06/21/2024
Location: Nairobi, Kenya
Subject: Understanding Industry Challenges and Opportunities to Improve the State of Pharmaceutical Manufacturing in Kenya
FDA Participant/Group: BETSY NEWCOMER; ANNA FERUS; JOHN WEINER;
Non FDA Participant/Group: Members of the Kenya Association of Pharmaceutical Industry

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/17/2024
Location: San Diego, CA
Subject: Drug Information Association 2024 Global Meeting; Opening Plenary and Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Drug Information Association 2024 Global Meeting

Event Date: 06/18/2024
Location: San Diego, CA
Subject: Drug Information Association 2024 Global Meeting; FDA Rare Disease Town Hall; FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Drug Information Association 2024 Global Meeting

Event Date: 06/21/2024
Location: Virtual
Subject: COVID-19 Vaccine Education and Equity Project Webinar: Aligning Strain Selection for COVID-19 and Flu Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the COVID-19 Vaccine Education and Equity Project Webinar

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 06/20/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Lisa Earnhardt, Gary Johnson, Nirav Dalal, Naveen Thuramalla, Shridhara Alva, Priya Jagasia, Barathi Sethuraman, Grant Kim, Rebecca Moreira, Jenn Jones-McMeans, Kartik Sundareswaran, Hassan Labay, Kristin Ruffner, Jenn Wong (Abbott)

Event Date: 06/20/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: OWEN FARIS; TROY TAZBAZ; SONJA FULMER; JESSICA PAULSEN;
Non FDA Participant/Group: Sumbul Desai, Divya Nahesh, David Amor, Sam Surette (Apple)

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 06/17/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: TRACEY FORFA; TRISTAN COLONIUS;
Non FDA Participant/Group: Joe Reardon, Stephanie McBath (National Association of State Departments of Agriculture (NASDA));

Event Date: 06/18/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: NATALIE MCKINNEY; MATTHEW BAKER; VANESSA WILLIAMS; TRISTAN COLONIUS;
Non FDA Participant/Group: Representatives of the Association of Food and Drug Officials (AFDO)

Event Date: 06/20/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of various federal and state government offices

Event Date: 06/21/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry

Event Date: 06/21/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: JEFFREY READ;
Non FDA Participant/Group: Industry, government, and other stakeholders

Event Date: 06/21/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: N/A
Non FDA Participant/Group: Advocacy groups, health care workers, industry, and other stakeholders

Event Date: 06/21/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: KIRSTEN BYERTS; NICHOLAS ALEXANDER;
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top